AnalyzeDirect Romine JS, Sipe JC, Koziol JA, Zyroff J, Beutler E. A double-blind, placebo-controlled, randomized trial of cladribine in relapsing-remitting multiple sclerosis. Proc Assoc Am Physicians. January 1999;111(1):35-44.
Publication Date
January 1999
How Analyze was Used
“All scans were interpreted and marked by the same neuroradiologist (JZ), who had no knowledge of patient treatment assignment. These were then duplicated by a technologist using the tpaaed raw data and a computer workstation [ANALYZE].”
Keywords
Administration, Cutaneous
Adult
Cladribine/administration & dosage
Double-Blind Method
Female
Humans
Immunosuppressive Agents/administration & dosage
Magnetic Resonance Imaging (MRI)
Male
Middle Aged
Multiple Sclerosis/drug therapy/physiopathology/radiography
Recurrence
Treatment Outcome
Author Affiliation(s)
Division of Neurology, Scripps Clinic, La Jolla, CA, US. (JS, JCS)
Department of Radiology, Scripps Clinic, La Jolla, CA, US. (JZ)
Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, US. (JAK, EB)
ID# 2934
Tags: Adult, Cladribine/administration & dosage, Cutaneous Administration, Double-Blind Method, Female, Humans, Immunosuppressive Agents/administration & dosage, Magnetic Resonance Imaging (MRI), Male, Middle Aged, Multiple Sclerosis/drug therapy/physiopathology/radiography, Recurrence, Treatment Outcome